Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vaxcyte's Chief Technical Ops Officer Sells Shares


Focused on next-generation vaccines for bacterial diseases, this biotech just reported a notable insider sale amid a challenging year.

Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte (NASDAQ:PCVX), disposed of 9,743 shares in an open-market sale valued at approximately $454,891 according to the SEC Form 4 filing.

Transaction value based on SEC Form 4 weighted average purchase price ($46.69); post-Transaction value based on Jan. 2 market close ($46.46).

Continue reading


Source Fool.com

Like: 0
Share

Comments